** Shares of surgical-equipment maker Teleflex TFX.N rise 14.2% to $130.03 premarket
** Company raises its full-year adjusted revenue growth outlook from between 1% and 2% to 7.70% to 8.70%, reflecting the acquisition of the BIOTRONIK's Vascular Intervention business
** Adds acquisition is expected to generate revenues of $204 million in H2 2025
** Also raises its 2025 adjusted profit per share outlook from a $13.20 to $13.60 range to $13.90 to $14.30
** Analysts had expected a profit of $13.37 per share
** For the quarter, company reported adjusted profit of $3.73 versus estimate of $3.36
** Up to last close, stock down 36% YTD
(Reporting by Sriparna Roy in Bengaluru)
((Sriparna.Roy@thomsonreuters.com;))